ACE inhibitors and urinary tract infections.
Department of Pharmacy, Unit of PharmacoEpidemiology and PharmacoEconomics (PE), University of Groningen, Groningen, The Netherlands, k.b.pouwels@rug.nl.
Koen B
KB
Pouwels
Jens H J
JH
Bos
Eelko
E
Hak
D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D016001:Confidence Intervals; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000627:therapeutic use; D016017:Odds Ratio; D018570:Risk Assessment; D014552:Urinary Tract Infections / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009582:Nitrofurantoin